Fresa, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 362
EU - Europa 342
AS - Asia 96
SA - Sud America 4
AF - Africa 2
OC - Oceania 1
Totale 807
Nazione #
US - Stati Uniti d'America 360
IT - Italia 141
SE - Svezia 67
SG - Singapore 50
IE - Irlanda 33
DE - Germania 30
CN - Cina 27
RU - Federazione Russa 17
CZ - Repubblica Ceca 11
FI - Finlandia 11
FR - Francia 9
IN - India 8
ES - Italia 6
GB - Regno Unito 5
CO - Colombia 3
HK - Hong Kong 3
IR - Iran 3
KR - Corea 3
PL - Polonia 3
AT - Austria 2
CI - Costa d'Avorio 2
NL - Olanda 2
UA - Ucraina 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
IL - Israele 1
MC - Monaco 1
MX - Messico 1
PT - Portogallo 1
TR - Turchia 1
Totale 807
Città #
Chandler 89
Ashburn 47
Rome 38
Singapore 37
Florence 36
Dublin 33
New York 26
Milan 23
Moscow 14
Bremen 12
Princeton 12
Boston 9
Chicago 8
Los Angeles 8
Marseille 8
San Mateo 8
Wilmington 8
Beijing 7
Brno 7
Lappeenranta 6
Munich 6
Washington 6
Helsinki 5
North Hollywood 5
Pavia 5
Brdo 4
Turin 4
Arezzo 3
Bogotá 3
Central 3
Fairfield 3
Nuremberg 3
Pune 3
San Marzano sul Sarno 3
Seoul 3
Seville 3
Abidjan 2
Amsterdam 2
Bangalore 2
Cattolica 2
Garden City 2
Gdansk 2
Guangzhou 2
London 2
Michigan City 2
Napoli 2
Norwalk 2
Redwood City 2
Vienna 2
Vigo 2
Woodbridge 2
Zanjan 2
Albuquerque 1
Augusta 1
Berlin 1
Brussels 1
Busto Arsizio 1
Chiswick 1
Clifton 1
Dearborn 1
Forest City 1
Frankfurt am Main 1
Gragnano 1
Haikou 1
Hefei 1
Houston 1
Hyderabad 1
Jacksonville 1
Jiaxing 1
Kashan 1
Lisbon 1
Monaco 1
Mumbai 1
Nizhniy Novgorod 1
Ottaviano 1
Phoenix 1
Santa Clara 1
Santarcangelo di Romagna 1
Seattle 1
Segni 1
Shanghai 1
Stockholm 1
Vancouver 1
Vinhedo 1
Warsaw 1
Totale 563
Nome #
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 67
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 56
the concomitance of lymphoma and breast carcinoma in the bone 54
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 46
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 44
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 44
The concomitance of lymphoma and breast carcinoma in the bone 42
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 41
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 41
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 39
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 35
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 34
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 29
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 27
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 25
Richter transformation in Chronic Lymphocytic Leukemia 24
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 23
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 22
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 21
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 20
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 20
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 17
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 15
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 13
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 13
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 11
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 7
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 7
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 5
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 5
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 5
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study 2
Role of microRNAs in Chronic Lymphocytic Leukemia 2
Totale 856
Categoria #
all - tutte 6.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 5 1 0 0 0 9 2
2020/20218 0 0 0 0 1 0 2 0 2 0 3 0
2021/202290 0 3 7 2 8 0 1 10 6 0 35 18
2022/2023314 38 37 14 37 25 28 13 23 48 17 31 3
2023/2024374 6 68 22 37 16 57 32 21 2 27 31 55
2024/202553 22 19 12 0 0 0 0 0 0 0 0 0
Totale 856